Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-HGF/SF Antibody (TAK-701) represents a highly specialized humanized monoclonal antibody specifically engineered to target the human hepatocyte growth factor which acts as a pivotal ligand for the c-Met receptor tyrosine kinase across various malignancies, effectively facilitating the measurable neutralization of HGF-induced signaling to evaluate its role in cancer cell survival and metastasis during strictly monitored laboratory observation periods.

| Description | Anti-HGF/SF Antibody (TAK-701) represents a highly specialized humanized monoclonal antibody specifically engineered to target the human hepatocyte growth factor which acts as a pivotal ligand for the c-Met receptor tyrosine kinase across various malignancies, effectively facilitating the measurable neutralization of HGF-induced signaling to evaluate its role in cancer cell survival and metastasis during strictly monitored laboratory observation periods. |
| In vitro | In co-culture assays using NSCLC cell lines and HGF-secreting fibroblasts, Anti-HGF/SF Antibody (TAK-701) blocked HGF-induced c-MET phosphorylation and reversed gefitinib resistance [1]. |
| In vivo | In mouse models of NSCLC with tumor-derived HGF, systemic administration of Anti-HGF/SF Antibody (TAK-701) suppressed tumor growth and enhanced the efficacy of EGFR inhibitors [1]. |
| Synonyms | TAK-701 |
| Clone | TAK-701 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | HGF/SF |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.